HALO - HALOZYME THERAPEUTICS, INC.
70.02
0.620 0.885%
Share volume: 1,660,590
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$69.40
0.62
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 10-31-2024 | 02-18-2025 | 05-06-2025 | 08-05-2025 | 11-03-2025 | 02-17-2026 | |
| Total revenue | 195.879 M | 231.353 M | 290.084 M | 298.008 M | 264.861 M | 325.719 M | 354.264 M | 451.767 M | |
| Cost of revenue | 28.329 M | 39.607 M | 49.426 M | 42.055 M | 48.403 M | 46.359 M | 55.242 M | 78.770 M | |
| Gross profit | 167.550 M | 191.746 M | 240.658 M | 255.953 M | 216.458 M | 279.360 M | 299.022 M | 372.997 M | |
| 14.44% | 25.51% | 6.36% | -15.43% | 29.06% | 7.04% | 24.74% | |||
| Operating expenses | 54.245 M | 56.749 M | 59.699 M | 62.690 M | 57.161 M | 59.157 M | 63.339 M | 393.812 M | |
| Selling general and admin | 35.134 M | 35.711 M | 41.241 M | 42.249 M | 42.362 M | 41.614 M | 46.088 M | 77.028 M | |
| Research and development | 19.111 M | 21.038 M | 18.458 M | 20.441 M | 14.799 M | 17.543 M | 17.251 M | 316.784 M | |
| Total expenses | 72.008 M | 74.511 M | 77.461 M | 80.452 M | 74.923 M | 76.919 M | 81.101 M | 465.888 M | |
| 3.48% | 3.96% | 3.86% | -6.87% | 2.66% | 5.44% | 474.45% | |||
| Operating income | 95.542 M | 117.235 M | 163.197 M | 175.501 M | 141.535 M | 202.441 M | 217.921 M | -92.891 M | |
| Ebit | 100.535 M | 122.267 M | 169.671 M | 182.754 M | 148.353 M | 209.332 M | 223.254 M | -90.461 M | |
| Pretax income | 96.028 M | 117.743 M | 165.147 M | 178.214 M | 143.828 M | 204.938 M | 218.958 M | -100.849 M | |
| 22.61% | 40.26% | 7.91% | -19.29% | 42.49% | 6.84% | -146.06% | |||
| Income tax | 19.205 M | 24.498 M | 28.136 M | 41.202 M | 25.733 M | 39.778 M | 43.733 M | 40.742 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 76.823 M | 93.245 M | 137.011 M | 137.012 M | 118.095 M | 165.160 M | 175.225 M | -141.591 M | |
| 21.38% | 46.94% | 0.00% | -13.81% | 39.85% | 6.09% | -180.81% |